EPISODE · May 9, 2025 · 30 MIN
Rebuilding from Brink: A Veteran's Stem Cell Journey with Nico Seedsman
from Voices in Health and Wellness · host Dr Andrew Greenland
Send us Fan MailWhat happens when a decorated special forces veteran faces certain death from complete autoimmune failure? For Nico Seedsman, founder of Odin Stem Cells, it became the catalyst for a revolutionary approach to regenerative medicine.After 13 years of military service including over eight years in the SAS, Seedsman's body was breaking down catastrophically – broken bones, worn joints, nervous system failure, multiple active tropical viruses, and complete autoimmune shutdown. When doctors quietly suggested he had months to live, a serendipitous connection to stem cell therapy not only saved his life but completely regenerated his damaged body.This transformative healing experience revealed a troubling gap: veterans who sacrifice their health in service have limited access to these life-changing therapies. Seedsman's mission evolved from creating a foundation to building Odin Stem Cells, a comprehensive ecosystem making regenerative medicine accessible, effective, and affordable.The conversation explores how Odin differentiates itself through three core principles: safety with experienced practitioners, efficacy using only the highest quality non-replicated cells, and fair pricing that eliminates the predatory margins common in the industry. We witness how the regulatory landscape is evolving, with state-by-state legalization improving standards, while technological advances like exosomes dramatically enhance treatment outcomes.What truly sets Odin apart, however, is their measure of success – not profit margins but healing metrics. Has the patient met their primary health goals? Were their top three objectives achieved? This patient-centered approach extends to offering multiple treatment plans at different price points, ensuring financial constraints don't automatically exclude individuals from care.Seedsman's story represents a powerful intersection of personal trauma, scientific advancement, and ethical business practices. By prioritizing integrity and genuine outcomes over profit, Odin Stem Cells offers a glimpse into how healthcare might evolve when driven by those who have experienced both profound suffering and remarkable healing.Have you considered how regenerative medicine might transform chronic health conditions that conventional medicine considers permanent? The possibilities may be more accessible than you realize. 📇 Guest Contact Details & Social Media Name: Nico SeedsmanTitle: CEO & Co-Founder, Odin Stem CellsEmail: [email protected]: +1 689-202-4879Instagram: @niclonewolfLinkedIn: Nicholas SeedsmanIMDb: Nico Seedsman About Dr Andrew GreenlandDr Andrew Greenland is a UK-based medical doctor and founder of Greenland Medical, specialising in Integrative and Functional Medicine. With dual training in conventional and root-cause approaches, he helps individuals optimise health, performance, and longevity — with a focus on cognitive resilience and healthy ageing.Voices in Health and Wellness features meaningful conversations at the intersection of medicine, lifestyle, and human potential — with clinicians, scientists, and thinkers shaping the future of care.💌 Join the mailing list for new episodes and exclusive reflections: https://subscribe.voicesinhealthandwellness.com
What this episode covers
Send us Fan Mail What happens when a decorated special forces veteran faces certain death from complete autoimmune failure? For Nico Seedsman, founder of Odin Stem Cells, it became the catalyst for a revolutionary approach to regenerative medicine. After 13 years of military service including over eight years in the SAS, Seedsman's body was breaking down catastrophically – broken bones, worn joints, nervous system failure, multiple active tropical viruses, and complete autoimmune shutdown. W...
NOW PLAYING
Rebuilding from Brink: A Veteran's Stem Cell Journey with Nico Seedsman
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m